News & Updates
Lung Cancer Canada held its AGM on June 14, electing a new President and one new board member to LCC’s Board of Directors.
Webinar: Thursday July 8, 2:00-3:00 pm EDT
A panel discussion of the latest advances inthe treatment of Mesothelioma. Featuring Dr Anna Nowak and Dr. Dr Quincy Chu. Moderated by Dr. Paul Wheatley-Price.
Cancer patient groups across Canada call for 2nd COVID-19 dose to be given to cancer patients according to best evidence- 21 to 28 days, not 4 weeks.
Alberta approves 21 or 28 day COVID-19 vaccine interval for cancer patients on active treatment
Lymphoma Canada, Myeloma Canada, Save Your Skin Foundation and Lung Cancer Canada ask the Provincial Governments for timely administration of second COVID-19 vaccines for immunocompromised patients, prioritization of the vaccine for household members of patients receiving immunosuppressive therapy, and increased guidance on the COVID-19 vaccine specific for cancer patients.
Join lung cancer patients around the world who are sharing their experience of lung cancer care.
New Ontario VCAG recommendations for COVID-19 vaccine intervals for cancer patients.
RELEASE (Toronto/ March 11, 2021)
A panel discussion of the latest advances in immunotherapy for the treatment of lung cancer. Featuring Dr. Julie Brahmer and Dr. Rosalyn Juergens. Moderated by Dr. Paul Wheatley-Price.